These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28218369)

  • 1. Effect of Intravitreal Aflibercept on Central Retinal Arterial Blood Flow in Type 1 Retinopathy of Prematurity.
    Sukgen EA; Söker G; Koçluk Y; Gülek B
    Eur J Ophthalmol; 2017 Nov; 27(6):751-755. PubMed ID: 28218369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intravitreal aflibercept (Eylea
    Gok M; Kapti HB
    Int Ophthalmol; 2018 Apr; 38(2):713-719. PubMed ID: 28421399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity.
    Huang CY; Lien R; Wang NK; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC; Wu WC
    Graefes Arch Clin Exp Ophthalmol; 2018 Mar; 256(3):479-487. PubMed ID: 29290015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of orbital blood flow velocities in retinopathy of prematurity.
    Ozcan PY; Dogan F; Sonmez K; Con R; Dokumaci DS; Seyhanli ES
    Int Ophthalmol; 2017 Aug; 37(4):795-799. PubMed ID: 27591784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intravitreal aflibercept monotherapy in retinopathy of prematurity evaluated by periodic fluorescence angiography and optical coherence tomography.
    Vural A; Perente İ; Onur İU; Eriş E; Seymen Z; Hergünsel GO; Salihoğlu Ö; Yiğit FU
    Int Ophthalmol; 2019 Oct; 39(10):2161-2169. PubMed ID: 30478752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity.
    Sukgen EA; Koçluk Y
    Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):49-55. PubMed ID: 30397793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Single Intravitreal Bevacizumab on Ophthalmic and Middle Cerebral Arterial Blood Flow in Retinopathy of Prematurity.
    Gunay M; Tuten A; Sancak S; Celik G; Bardak H; Dincer E; Karatekin G; Erdogan G; Bardak Y
    Ophthalmic Res; 2016; 55(4):165-71. PubMed ID: 26820969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity.
    Vedantham V
    Indian J Ophthalmol; 2019 Jun; 67(6):884-888. PubMed ID: 31124509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Efficacy Between Intravitreal Aflibercept and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity.
    Ekinci DY; Çelik K
    J Pediatr Ophthalmol Strabismus; 2020 Jan; 57(1):54-60. PubMed ID: 31972042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal blood flow velocities in infants with retinopathy of prematurity after intravitreal administration of bevacizumab.
    Mohr FH; Fischer HS; Czernik C; Müller B; Bührer C
    Eur J Ophthalmol; 2024 Jan; 34(1):95-101. PubMed ID: 37218176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial.
    Stahl A; Sukgen EA; Wu WC; Lepore D; Nakanishi H; Mazela J; Moshfeghi DM; Vitti R; Athanikar A; Chu K; Iveli P; Zhao F; Schmelter T; Leal S; Köfüncü E; Azuma N;
    JAMA; 2022 Jul; 328(4):348-359. PubMed ID: 35881122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effects of intravitreal bevacizumab (Avastin(®)) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration.
    Toklu Y; Cakmak HB; Raza S; Anayol A; Asik E; Simşek S
    Acta Ophthalmol; 2011 Feb; 89(1):e41-5. PubMed ID: 21232081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Aflibercept Treatment and Its Effect on the Retinal Perfusion in the Oxygen-Induced Retinopathy Mouse Model of Retinopathy of Prematurity.
    Amin SM; Gonzalez A; Guevara J; Bolch C; Andersen L; Smith WC; Agarwal-Sinha S
    Ophthalmic Res; 2021; 64(1):91-98. PubMed ID: 32535604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.
    Stahl A; Nakanishi H; Lepore D; Wu WC; Azuma N; Jacas C; Vitti R; Athanikar A; Chu K; Iveli P; Zhao F; Leal S; Schlief S; Schmelter T; Miller T; Köfüncü E; Fielder A;
    JAMA Netw Open; 2024 Apr; 7(4):e248383. PubMed ID: 38687481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravitreal bevacizumab on retrobulbar blood flow of patients with diabetic macular edema.
    Örnek N; Inal M; Erbahceci IE; Oğurel T; Örnek K
    Eur J Ophthalmol; 2015; 25(6):539-45. PubMed ID: 25907286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANATOMICAL AND FUNCTIONAL RESULTS OF INTRAVITREAL AFLIBERCEPT MONOTHERAPY FOR TYPE 1 RETINOPATHY OF PREMATURITY: One-Year Outcomes.
    Chen YT; Liu L; Lai CC; Chen KJ; Hwang YS; Wu WC
    Retina; 2020 Dec; 40(12):2366-2372. PubMed ID: 31996587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum vascular endothelial growth factor, insulin-like growth factor-1 and aflibercept levels in retinopathy of prematurity.
    Furuncuoglu U; Vural A; Kural A; Onur IU; Yigit FU
    Jpn J Ophthalmol; 2022 Mar; 66(2):151-158. PubMed ID: 35091863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.
    Stahl A; Azuma N; Wu WC; Lepore D; Sukgen E; Nakanishi H; Mazela J; Leal S; Pieper A; Schlief S; Eissing T; Turner KC; Zhao A; Winkler J; Höchel J; Köfüncü E; Zimmermann T;
    Eye (Lond); 2024 Jun; 38(8):1444-1453. PubMed ID: 38200320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration.
    Hosseini H; Lotfi M; Esfahani MH; Nassiri N; Khalili MR; Razeghinejad MR; Nouri-Mahdavi K
    Retina; 2012 May; 32(5):967-71. PubMed ID: 22146127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Color doppler imaging of the central retinal artery in premature infants undergoing examination for retinopathy of prematurity.
    Holland DR; Saunders RA; Kagemann LE; Bluestein EC; Hutchinson AK; Corson DW; Harris A
    J AAPOS; 1999 Aug; 3(4):194-8. PubMed ID: 10477220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.